Skip to main content
. 2018 Sep 21;265(12):2815–2824. doi: 10.1007/s00415-018-9063-9

Table 1.

Baseline characteristics (randomized population)

Demographic characteristics Pregabalin (n = 275) Placebo (n = 267) Total (N = 542)
Age (years)
 Mean (SD) 52.8 (12.9) 53.5 (12.6) 53.1 (12.8)
 Range 20–81 20–85 20–85
Age, years, no. (%) of patients
 18–44 60 (21.8) 61 (22.8) 121 (22.3)
 45–64 163 (59.3) 156 (58.4) 319 (58.9)
 ≥ 65 52 (18.9) 50 (18.7) 102 (18.8)
Race, no. (%) of patients
 White 217 (78.9) 215 (80.5) 432 (79.7)
 Black 47 (17.1) 46 (17.2) 93 (17.2)
 Asian 7 (2.5) 3 (1.1) 10 (1.8)
 Other 4 (1.5) 3 (1.1) 7 (1.3)
Weight (kg)
Mean (SD) 85.9 (20.0) 86.2 (19.0) 86.1 (19.5)
 Range 49.1–193.7 45.4–166.0 45.4–193.7
Height (cm)
Mean (SD) 170.1 (10.1) 168.6 (9.4) 169.4 (9.8)
 Range 142.2–198·0 140.0–198.1 140.0–198.1
Trauma type, no. (%) of patients
 Surgical 131 (47.6) 138 (51.7) 269 (49.6)
 Non-surgical 144 (52.4) 129 (48.3) 273 (50.4)
Baseline mean pain (daily NRS)
 Mean (SD) 6.41 (1.3) 6.5 (1.3)
Questionnaire: PainDETECT [13] N = 274 N = 265
 Mean (SD) 23.1 (5.52) 22.6 (5.52)
 Range 2–36 3–38

NRS numeric rating scale, SD standard deviation